Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Diabetes

Insulin pens recalled

The MHRA has warned diabetes patients who use insulin pens manufactured by Novo Nordisk that some batches of the pens might have had faulty cartridge holders, resulting in under-delivery of insulin.

Insulin pens recalled

Source: Shutterstock.com

Novo Nordisk have issued a product recall for the batches of NovoPen Echo and NovoPen 5 because of faulty cartridge holders, which may result in under-delivery of insulin

Pharmacists have been told to ensure they do not dispense from 87 batches of insulin pens that could leave patients at risk of hyperglycaemia.

The Medicines and Healthcare products Regulatory Agency (MHRA) has warned diabetes patients who use two types of pens manufactured by Novo Nordisk that the insulin cartridge holder in some batches may crack or break if it is exposed to certain chemicals, which include household cleaning products.

This could result in an under-delivery of insulin, which could have serious health implications for users.

The manufacturers have issued a product recall for the batches of NovoPen Echo and NovoPen 5, from wholesalers and pharmacies, and patients are being asked to return pens from the affected batches.

Details of the batches involved are available on the MHRA website.

MHRA director of medical services, John Wilkinson, said: “It is important patients do not stop treatment without contacting their diabetes management team.

“We are asking people using a NovoPen Echo and/or NovoPen 5 from one of the affected batches to contact Novo Nordisk to replace the cartridge holder as some could be damaged or subject to damage in the future.”

Wilkinson said the MHRA continued to encourage people to use its Yellow Card scheme to report any problems with medical devices.

This allows users to report side effects, safety concerns, counterfeit and defective medicines, and medical device adverse incidents.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203459

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Insulin pens recalled

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.